Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ab Trill

10% Owner at DiaMedica Therapeutics Inc. (DMAC)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-11.1%
vs. S&P 500-10.6%
Beat the market0%
Paper profit on buys+$1.2M
Total bought / sold$7.6M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Dec 8SEC DMACDiaMedica Therapeutics Inc. Buy 187,3937,951,858 held (+2%) $6.52 $1.2M +27.8%
Dec 8SEC DMACDiaMedica Therapeutics Inc. Buy 182,8828,134,740 held (+2%) $6.75 $1.2M +23.4%
Dec 8SEC DMACDiaMedica Therapeutics Inc. Buy 240,3528,375,092 held (+3%) $7.21 $1.7M +15.5%
Dec 8SEC DMACDiaMedica Therapeutics Inc. Buy 128,4268,503,518 held (+2%) $7.41 $952K +12.4%
Dec 8SEC DMACDiaMedica Therapeutics Inc. Buy 208,8728,712,390 held (+2%) $7.41 $1.5M +12.4%
Dec 8SEC DMACDiaMedica Therapeutics Inc. Buy 40,2538,752,643 held (+0%) $7.89 $318K +5.6%
Dec 8SEC DMACDiaMedica Therapeutics Inc. Buy 73,0998,825,742 held (+1%) $8.57 $626K -2.8%
  • Buy

    10% Owner Ab Trill bought $1.2M of DMAC at $6.52 — first open-market purchase in our records.

  • Buy

    10% Owner Ab Trill bought $1.7M of DMAC at $7.21 — largest purchase by this insider in our records.